Liquidia (NASDAQ:LQDA) Research Coverage Started at HC Wainwright

HC Wainwright began coverage on shares of Liquidia (NASDAQ:LQDA – Free Report) in a report published on Friday morning, MarketBeat reports. The brokerage issued a buy rating and a $76.00 price target on the stock.

A number of other analysts also recently weighed in on the stock. Weiss Ratings raised shares of Liquidia from a “sell (d-)” rating to a “hold (c)” rating in a report on Tuesday, September 22nd. Stephens set a $130.00 price objective on shares of Liquidia in a report on Friday, July 24th. Wedbush set a $58.00 price objective on shares of Liquidia in a report on Friday, October 2nd. Wells Fargo & Company upped their price objective on shares of Liquidia from $33.00 to $40.00 and gave the company an “equal weight” rating in a research report on Wednesday, November 11th. Finally, Citigroup reiterated a “neutral” rating on shares of Liquidia in a research note on Thursday, October 1st. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $75.23.

Get Our Latest Analysis on LQDA

Liquidia Price Performance

Shares of LQDA stock opened at $57.41 on Friday. Liquidia has a 12 month low of $22.31 and a 12 month high of $93.61. The company has a quick ratio of 0.96, a current ratio of 1.02 and a debt-to-equity ratio of 0.63. The firm has a market cap of $5.17 billion, a PE ratio of -46.67 and a beta of 0.40. The stock has a 50 day moving average of $48.96 and a 200-day moving average of $54.75.

Liquidia (NASDAQ:LQDA – Get Free Report) last announced its quarterly earnings data on Tuesday, November 10th. The company reported ($2.64) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.96 by ($3.60). Liquidia had a positive return on equity of 264.65% and a negative net margin of 15.15%. The company had revenue of $225.30 million during the quarter, compared to analyst estimates of $214.18 million. During the same quarter in the previous year, the business posted ($0.04) EPS. The company’s revenue was up 314.9% on a year-over-year basis. On average, equities analysts predict that Liquidia will post -0.25 EPS for the current year.

Insider Transactions at Liquidia

In other Liquidia news, Director Stephen M. Bloch sold 235,477 shares of the business’s stock in a transaction on Monday, October 5th. The shares were sold at an average price of $27.13, for a total value of $6,388,491.01. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Roger Jeffs sold 32,744 shares of the stock in a transaction on Monday, October 12th. The shares were sold at an average price of $28.48, for a total transaction of $932,549.12. Following the completion of the transaction, the chief executive officer owned 1,125,848 shares of the company’s stock, valued at approximately $32,064,151.04. This represents a 2.83% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 537,045 shares of company stock valued at $23,476,727 over the last 90 days. Corporate insiders own 25.60% of the company’s stock.

Institutional Trading of Liquidia

Institutional investors have recently made changes to their positions in the business. Pinnacle Wealth Planning Services Inc. raised its position in Liquidia by 26.2% in the third quarter. Pinnacle Wealth Planning Services Inc. now owns 1,557 shares of the company’s stock worth $47,000 after purchasing an additional 323 shares in the last quarter. Sterling Capital Management LLC lifted its stake in Liquidia by 839.1% during the third quarter. Sterling Capital Management LLC now owns 2,329 shares of the company’s stock worth $70,000 after purchasing an additional 2,081 shares during the period. Nisa Investment Advisors LLC boosted its holdings in Liquidia by 13.8% during the third quarter. Nisa Investment Advisors LLC now owns 2,634 shares of the company’s stock valued at $80,000 after purchasing an additional 320 shares in the last quarter. Globeflex Capital L P acquired a new stake in Liquidia during the second quarter valued at approximately $175,000. Finally, Nykredit A S acquired a new stake in Liquidia during the second quarter valued at approximately $177,000. 64.54% of the stock is currently owned by institutional investors and hedge funds.

About Liquidia

(Get Free Report)

Liquidia Corporation is a biopharmaceutical company focused on developing and commercializing treatments for pulmonary hypertension and other serious diseases. Its work includes inhaled therapies designed to deliver medicines to the lungs. The company’s marketed product, Yutrepia (treprostinil) inhalation powder, is approved in the United States for adults with pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease. Liquidia also has a pipeline of investigational therapies, including other formulations of treprostinil.

Recommended Stories

Analyst Recommendations for Liquidia (NASDAQ:LQDA)

Receive News & Ratings for Liquidia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liquidia and related companies with MarketBeat.com's FREE daily email newsletter.